Innate Pharma S.A. (IPHA)

Innate Pharma Revenue

In the year 2025, Innate Pharma had annual revenue of 9.01M EUR, down -55.25%. Innate Pharma had revenue of 4.15M in the half year ending December 31, 2025, a decrease of -80.67%.

• Revenue (ttm): 9.01M EUR
• Revenue Growth: -66.59%
• P/S Ratio: 8.08
• Revenue / Employee: 51,753 EUR
• Employees: 174
• Market Cap: 119.96M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.01M	-11.12M	-55.25%
Dec 31, 2024	20.12M	-41.52M	-67.36%
Dec 31, 2023	61.64M	3.97M	6.88%
Dec 31, 2022	57.67M	32.97M	133.47%
Dec 31, 2021	24.70M	-45.07M	-64.60%
Dec 31, 2020	69.77M	-15.68M	-18.35%
Dec 31, 2019	85.45M	-8.50M	-9.05%
Dec 31, 2018	93.95M	49.92M	113.37%
Dec 31, 2017	44.03M	-21.69M	-33.00%
Dec 31, 2016	65.72M	40.58M	161.41%
Dec 31, 2015	25.14M	17.52M	229.80%
Dec 31, 2014	7.62M	-9.03M	-54.22%
Dec 31, 2013	16.65M	2.37M	16.59%
Dec 31, 2012	14.28M	-	-